New registry tracks Drug-Coated Balloon's Real-World performance in chinese heart patients

NCT ID NCT04085445

Completed Knowledge-focused Sponsor: Boston Scientific Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed registry study followed 500 Chinese patients who received the Agent DCB, a paclitaxel-coated balloon catheter, during a heart procedure to open blocked arteries. The goal was to collect real-world data on heart-related events like heart attacks or repeat procedures over 12 months. The study did not test a new treatment but rather observed outcomes in routine practice.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: paclitaxel-coated balloon catheter
What this could lead to: If successful, this registry could provide real-world evidence on how well the Agent DCB balloon works for treating blocked heart arteries in Chinese patients.
What could go wrong: This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may not apply to other populations or devices.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHINESE PATIENTS TREATED WITH AGENT DCB are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHINESE PATIENTS TREATED WITH AGENT DCB

Contacts and locations

Locations

Cheng Hsin General Hospital

Taipei, Taiwan
China Medical University Hospital

Taichung, Taiwan
Hualien Tzu Chi Hospital

Hualien City, 970, Taiwan
Kaohsiung Veterans General Hospital

Kaohsiung City, Taiwan
Mackay Memorial Hospital

Taipei, Taiwan
National Taiwan University Hospital

Taipei, Taiwan
Queen Mary Hospital

Hong Kong, Hong Kong
Taipei Veterans General Hospital

Taipei, Taiwan
Tan Tock Seng Hospital

Singapore, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.